Donor-specific cytokine production by graft-infiltrating lymphocytes induces and maintains graft vascular disease in human cardiac allografts

Transplantation

Volumn 63, Issue 9, 1997, Pages 1313-1318

  Van Besouw, Nicole M ^a   Daane, Cornelis R ^a   Vaessen, Lenard M B ^a   Mochtar, Bas ^a   Balk, Aggie H M M ^a   Weimar, Willem ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 6;

ALLOGRAFT; ARTICLE; CELL INFILTRATION; CLINICAL ARTICLE; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; HELPER CELL; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL;

CELLS, CULTURED; CYTOKINES; HEART TRANSPLANTATION; HUMANS; SENSITIVITY AND SPECIFICITY; TH1 CELLS; TH2 CELLS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 0030909125     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199705150-00020     Document Type: Article

References (27)

1. Balk AHMM, Weimar W. Chronic heart graft rejection in the clinical setting. In: Paul LC, Solez K, eds. Organ transplantation: long-term results. New York: Marcel Dekker, 1992: 187.
2. Häyry P, Isoniemi H, Yilmaz S, et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33.
3. Tullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic rejection. Transplantation 1995; 59: 313.
4. Balk AHMM, Simoons ML, Van der Linden MJMM, et al. Coronary artery disease after heart transplantation: timing of coronary arteriography. J Heart Lung Transplant 1993; 12: 89.
5. Tilney NL, Whitley WD, Daimond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection: an undefined conundrum. Transplantation 1991; 52: 389.
6. Paul LC, Fellstrom B. Chronic vascular rejection of the heart and the kidney: have rational treatment options emerged? Transplantation 1992; 53: 1169.
7. Paul LC. Growth factors in chronic rejection. Transplant Sci 1993; 3: 113.
8. Van Besouw NM, Daane CR, Vaessen LMB, et al. Different patterns in donor-specific production of T-helper 1 and 2 cytokines by cells infiltrating the rejecting cardiac allograft. J Heart Lung Transplant 1995; 14: 816.
9. Vaessen LMB, Ouwehand AJ, Baan CC, et al. Phenotypic and functional analysis of T cell receptor γδ-bearing cells isolated from human heart allograft. J Immunol 1991; 147: 846.
10. Orosz CG. Endothelial activation and chronic allograft rejection. Clin Transplant 1994; 8: 299.
11. Fuggle SV, Sanderson JB, Gray DWR, et al. Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys: correlation with intragraft events. Transplantation 1993; 55: 117.
12. Van Besouw NM, Balk AHMM, Mochtar B, Vaessen LMB, Weimar W. Phenotypic analysis of lymphocytes infiltrating human cardiac allografts during acute rejection and the development of graft vascular disease. Transplant Int 1996; 9 (suppl): S234.
13. Rickenbacher PR, Kemna MS, Pinto FJ, et al. Coronary artery intimal thickening in the transplanted heart: an in vivo intracoronary ultrasound study of immunologic and metabolic risk factors. Transplantation 1996; 61: 46.
14. Tilney NL, Whitley WD, Tullius SG, et al. Serial analysis of cytokines, adhesion molecule expression, and humoral responses during the development of chronic kidney allograft rejection in a new rat model. Transplant Proc 1993; 25: 861.
15. Hancock WH, Whitley WD, Tullius SG, et al. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993; 56: 643.
16. Russell ME, Wallace AF, Hancock WW, et al. Upregulation of cytokines associated with macrophage activation in the Leis-to-F334 rat transplantation model of chronic rejection. Transplantation 1995; 59: 572.
17. Hayashi M, Martinez OM, Garcia-Kennedy R, So S, Esquivel CO, Krams SM. Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 1995; 60: 1533.
18. Bishop GA, Rokahr KL, Napoli J, McCaughan GW. Intragraft cytokine mRNA levels in human liver allograft rejection analysed by reverse transcription and semiquantitative polymerase chain reaction amplification. Transplant Immunol 1993; 1: 253.
19. Noronha IL, Eberlein-Gonska M, Hartley B, Stephens S, Cameron JS, Waldherr R. In situ expression of tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 receptors in renal allograft biopsies. Transplantation 1992; 54: 1017.
20. + graft-infiltrating lymphocytes in promptly rejected kidney allografts. Transplantation 1995; 59: 1113.
21. Taniguchi T, Minami Y. The IL-2/IL-2 receptor system: a current overview. Cell 1993; 73: 5.
22. Halloran P, Goes N. Interferon-γ and its receptor. Transplant Sci 1993; 3: 92.
23. Gromo G, Geller RL, Inverardi L, Bach FH. Signal requirements in the step-wise functional maturation of cytotoxic T lymphocytes. Nature 1987; 327: 424.
24. Stuhler G, Walden P. Collaboration of helper and cytotoxic T lymphocytes. Eur J Immunol 1993; 23: 2279.
25. + allogeneic vascular endothelium. Transplantation 1993; 56: 128.
26. Newstead CG, Lamb WR, Brenchley PEC, Short CD. Serum and urine IL-6 and TNF-α in renal transplant recipients with graft dysfunction. Tranplantation 1993; 56: 831.
27. Helle M, Boeije L, De Groot E, De Vos A, Aarden L. Sensitive ELISA for interleukin-6: detection of IL-6 in biological fluids - synovial fluids and sera. J Immunol Methods 1991; 138: 47.